Switching from etravirine- to doravirine-containing regimen maintains viral suppression in people with HIV-1 infection, including those with archived resistance to NNRTIs.
Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...
The investigational oral therapy combines doravirine, a non-nucleoside reverse transcriptase inhibitor, with islatravir, a nucleoside reverse transcriptase translocation inhibitor, in a single tablet ...
If PIFELTRO is coadministered with rifabutin, increase PIFELTRO dosage to one tablet twice daily (approximately 12 hours apart). Consult the full Prescribing Information prior to and during treatment ...
HIV infections among Kerala's youth surge, with 62.6% linked to unsafe heterosexual practices; urgent prevention efforts ...
New HIV infections per 1,000 uninfected population, also known as ‘annual new HIV incidence rate’, stood at 0.05 nationally ...
Details of a 60-year-old male individual from Germany who achieved sustained HIV remission after a stem cell transplant, the ...
On World AIDS Day, advocates warn federal cuts could reverse progress.
The Kremlin has for years refused to acknowledge the scale of the HIV epidemic in Russia.
People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback